The use of an active placebo, glycopyronium, was able to produce antidepressant-like effects that were not distinguishable from those produced by an actual antidepressant, suggesting that the placebo effect may be responsible for a significant portion of the antidepressant response. This finding could have important implications for reducing healthcare costs associated with mental health issues such as depression and chronic anxiety.